drugset / Trial / NCT00801905
Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation
Non-randomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to determine whether topical nepafenac (qid) is effective in preventing and treating macular thickening related pan-retinal photocoagulation in patients with diabetic retinopathy.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-12
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nepafenac | Other / unclassified | 0.1 % | Topical |